EXAS Insider Trading

Insider Ownership Percentage: 1.20%
Insider Buying (Last 12 Months): $1,001,325.00
Insider Selling (Last 12 Months): $300,672.40

Exact Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at Exact Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3-$4M-$2M$0$2M$4MTotal Insider BuyingTotal Insider Selling

Exact Sciences Share Price & Price History

Current Price: $52.83
Price Change: Price Decrease of -0.837 (-1.56%)
As of 07/17/2025 03:26 PM ET

This chart shows the closing price history over time for EXAS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AugSepOctNovDecJanFebMarAprMayJunJul$53.67Closing price on 07/16/25:

SEC Filings (Institutional Ownership Changes) for Exact Sciences (NASDAQ:EXAS)

88.82% of Exact Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EXAS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$19Mbought$9.36MsoldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3-$5B$0$5BTotal InflowsTotal Outflows
Exact Sciences logo
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Read More on Exact Sciences

Today's Range

Now: $52.83
Low: $52.31
High: $53.95

50 Day Range

MA: $54.37
Low: $51.17
High: $58.08

52 Week Range

Now: $52.83
Low: $39.97
High: $72.83

Volume

831,779 shs

Average Volume

2,569,302 shs

Market Capitalization

$9.97 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Exact Sciences?

Exact Sciences' top insider investors include:
  1. Kevin T Conroy (CEO)
  2. Sarah Condella (EVP)
  3. Katherine S Zanotti (Director)
  4. James Edward Doyle (Director)
  5. Everett Cunningham (Insider)
  6. D Scott Coward (Director)
  7. Daniel J Levangie (Director)
  8. Jacob A Orville (Insider)
  9. Brian Baranick (EVP)
  10. Jeffrey Thomas Elliott (CFO)
  11. James Herriott (SVP)
  12. James Herriott (General Counsel)
  13. Brian Baranick (Insider)
Learn More about top insider investors at Exact Sciences.

Who are the major institutional investors of Exact Sciences?

Exact Sciences' top institutional investors include:
  1. Zevenbergen Capital Investments LLC — 0.54%
  2. Kingstone Capital Partners Texas LLC — 0.15%
  3. Bank Pictet & Cie Europe AG — 0.09%
  4. Public Employees Retirement System of Ohio — 0.03%
  5. Harbor Capital Advisors Inc. — 0.03%
  6. Krilogy Financial LLC — 0.02%
Learn More about top institutional investors of Exact Sciences stock.

Which major investors are selling Exact Sciences stock?

In the previous quarter, EXAS stock was sold by these institutional investors:
  1. Zevenbergen Capital Investments LLC
  2. Channel Wealth LLC
  3. Krilogy Financial LLC
  4. Park Avenue Securities LLC
  5. Harbor Capital Advisors Inc.
  6. Beacon Investment Advisory Services Inc.
In the previous year, company insiders that have sold Exact Sciences company stock include:
  1. Kevin T Conroy (CEO)
  2. Sarah Condella (EVP)
Learn More investors selling Exact Sciences stock.

Which major investors are buying Exact Sciences stock?

During the previous quarter, EXAS stock was acquired by institutional investors including:
  1. Kingstone Capital Partners Texas LLC
  2. Bank Pictet & Cie Europe AG
  3. Waycross Partners LLC
  4. Pallas Capital Advisors LLC
  5. Ballentine Partners LLC
  6. Capital Asset Advisory Services LLC
  7. Diversified Trust Co
  8. Public Employees Retirement System of Ohio